相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacological effects of TAK-828F: an orally available RORt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease
Keiko Igaki et al.
INFLAMMATION RESEARCH (2019)
ILC3 function as a double-edged sword in inflammatory bowel diseases
Boning Zeng et al.
CELL DEATH & DISEASE (2019)
A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets
Marion Salou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation
Mingming Sun et al.
JOURNAL OF IMMUNOLOGY (2019)
Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available ROR gamma t inverse agonist
Akira Shibata et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
Vrajesh B. Pandya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients
Helena Bassolas-Molina et al.
FRONTIERS IN IMMUNOLOGY (2018)
A NOVEL ROR-GAMMA T INHIBITOR (VPR-254) ATTENUATES KEY PARAMETERS OF INNATE IMMUNE COLITIS IN MICE
Leo R. Fitzpatrick et al.
GASTROENTEROLOGY (2017)
Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
N. S. Ding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
David R. Withers et al.
NATURE MEDICINE (2016)
ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation
Claire Pearson et al.
ELIFE (2016)
Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease
Huiling Wang et al.
GENOME BIOLOGY (2016)
RORt+ hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice
Maria Martin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
90 Efficacy of a Novel Small Molecule RORgt Inverse Agonist in Mouse DSS and TNBS Models of Inflammatory Bowel Disease
Leo R. Fitzpatrick et al.
GASTROENTEROLOGY (2015)
The unusual suspects-innate lymphoid cells as novel therapeutic targets in IBD
Rimma Goldberg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
ROR nuclear receptors: structures, related diseases, and drug discovery
Yan Zhang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Cytokine crowdsourcing: multicellular production of TH17-associated cytokines
Kathleen O. Busman-Sahay et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism
A. Eken et al.
MUCOSAL IMMUNOLOGY (2014)
The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice
Leo R. Fitzpatrick et al.
INFLAMMOPHARMACOLOGY (2014)
Role of interleukin-21 isoform in dextran sulfate sodium (DSS)-induced colitis
Akemi Araki et al.
CYTOKINE (2013)
Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses
Qian-Qian Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Multi-Parameter Optimization: Identifying High Quality Compounds with a Balance of Properties
Matthew D. Segall
CURRENT PHARMACEUTICAL DESIGN (2012)
Inhibition of Pim-1 Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice
Yue-Ming Shen et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Small molecule inhibitors of RORγt: Targeting Th17 cells and other applications
Jun R. Huh et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Expression of chemokine CCL20 in ulcerative colitis
Haifeng Zhang et al.
MOLECULAR MEDICINE REPORTS (2012)
RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation
T. Kanai et al.
MUCOSAL IMMUNOLOGY (2012)
Vidofludimus Inhibits Colonic Interleukin-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action
Leo R. Fitzpatrick et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
Leo R. Fitzpatrick
INTERNATIONAL JOURNAL OF INFLAMMATION (2012)
Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells
Matthias Lochner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease
Alessandra Geremia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
4SC-101, a Novel Immunosuppressive Drug, Inhibits IL-17 and Attenuates Colitis in Two Murine Models of Inflammatory Bowel Disease
Leo R. Fitzpatrick et al.
INFLAMMATORY BOWEL DISEASES (2010)
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
Sofia Buonocore et al.
NATURE (2010)
Using the Golden Triangle to optimize clearance and oral absorption
Ted W. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
ROR gamma-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
Moritz Leppkes et al.
GASTROENTEROLOGY (2009)
The role of the novel Th17 cytokine IL-26 in intestinal inflammation
J. Dambacher et al.
GUT (2009)
In vitro and in vivo effects of the probiotic Escherichia coli strain M-17:: immunomodulation and attenuation of murine colitis
Leo R. Fitzpatrick et al.
BRITISH JOURNAL OF NUTRITION (2008)
Regulation of gut inflammation and Th17 cell response by interleukin-21
Daniele Fina et al.
GASTROENTEROLOGY (2008)
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma
Xuexian O. Yang et al.
IMMUNITY (2008)
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Holm H. Uhlig et al.
IMMUNITY (2006)
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis
Z Zhang et al.
INFLAMMATORY BOWEL DISEASES (2006)
分享论文
